Visual System Impairment in a Mouse Model of Krabbe Disease: The Twitcher Mouse.
Krabbe disease
Twitcher mouse
astrogliosis
psychosine
visual cortex
visual system
Journal
Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414
Informations de publication
Date de publication:
23 12 2020
23 12 2020
Historique:
received:
11
11
2020
revised:
18
12
2020
accepted:
19
12
2020
entrez:
30
12
2020
pubmed:
31
12
2020
medline:
24
6
2021
Statut:
epublish
Résumé
Krabbe disease (KD, or globoid cell leukodystrophy; OMIM #245200) is an inherited neurodegenerative condition belonging to the class of the lysosomal storage disorders. It is caused by genetic alterations in the gene encoding for the enzyme galactosylceramidase, which is responsible for cleaving the glycosydic linkage of galatosylsphingosine (psychosine or PSY), a highly cytotoxic molecule. Here, we describe morphological and functional alterations in the visual system of the Twitcher (TWI) mouse, the most used animal model of Krabbe disease. We report in vivo electrophysiological recordings showing defective basic functional properties of the TWI primary visual cortex. In particular, we demonstrate a reduced visual acuity and contrast sensitivity, and a delayed visual response. Specific neuropathological alterations are present in the TWI visual cortex, with reduced myelination, increased astrogliosis and microglia activation, and around the whole brain. Finally, we quantify PSY content in the brain and optic nerves by high-pressure liquid chromatography-mass spectrometry methods. An increasing PSY accumulation with time, the characteristic hallmark of KD, is found in both districts. These results represent the first complete characterization of the TWI visual system. Our data set a baseline for an easy testing of potential therapies for this district, which is also dramatically affected in KD patients.
Identifiants
pubmed: 33374753
pii: biom11010007
doi: 10.3390/biom11010007
pmc: PMC7824544
pii:
doi:
Substances chimiques
Psychosine
2238-90-6
Galactosylceramidase
EC 3.2.1.46
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Neurosci Res. 2011 Mar;89(3):352-64
pubmed: 21259322
Arch Ophthalmol. 1978 May;96(5):864-70
pubmed: 418756
Sci Rep. 2017 Jun 6;7(1):2858
pubmed: 28588216
Clin Neurophysiol. 2004 Jul;115(7):1653-6
pubmed: 15203066
Mol Ther. 2018 Mar 7;26(3):874-889
pubmed: 29433937
J Neurochem. 2007 Jun;101(5):1294-302
pubmed: 17442056
Brain Pathol. 1995 Jul;5(3):249-58
pubmed: 8520724
J Neurol Neurosurg Psychiatry. 1963 Jun;26:195-8
pubmed: 13951860
J Neurochem. 2020 Jul 28;:
pubmed: 33448358
Front Cell Dev Biol. 2020 Mar 04;8:132
pubmed: 32195255
J AAPOS. 2011 Dec;15(6):595-7
pubmed: 22153408
J Neurosci Res. 2016 Nov;94(11):982-9
pubmed: 27638583
J Neurochem. 1996 Mar;66(3):1118-24
pubmed: 8769874
Am J Ophthalmol. 1972 Sep;74(3):400-6
pubmed: 4115450
Arq Neuropsiquiatr. 2010 Oct;68(5):816-8
pubmed: 21049202
Sci Adv. 2019 Nov 20;5(11):eaax7462
pubmed: 31799395
J Neurosci Res. 2016 Nov;94(11):1031-6
pubmed: 27638588
Cell Death Dis. 2014 Nov 20;5:e1529
pubmed: 25412308
Nat Commun. 2020 Oct 23;11(1):5356
pubmed: 33097716
J Neurosci Res. 2016 Nov;94(11):1246-60
pubmed: 27638607
Front Cell Neurosci. 2014 Jun 17;8:163
pubmed: 24987331
J Inherit Metab Dis. 2013 Sep;36(5):859-68
pubmed: 23197103
Mol Vis. 2011;17:2212-20
pubmed: 21897743
Gene. 2015 Jan 15;555(1):2-13
pubmed: 25260228
Mol Genet Metab. 2020 Feb;129(2):161-164
pubmed: 31439510
Neurobiol Dis. 2019 Sep;129:195-207
pubmed: 31108173
Ann N Y Acad Sci. 1990;605:313-24
pubmed: 2268119
J Neurosci. 2003 Apr 15;23(8):3302-7
pubmed: 12716937
J Clin Invest. 2020 Sep 1;130(9):4906-4920
pubmed: 32773406
Dev Neurosci. 1991;13(4-5):240-4
pubmed: 1817027
Orphanet J Rare Dis. 2018 Aug 9;13(1):126
pubmed: 30089515
Behav Brain Res. 1987 Aug;25(2):143-53
pubmed: 3675825
Pediatr Res. 2007 Aug;62(2):156-62
pubmed: 17597652
Pediatr Neurol. 2000 Jan;22(1):44-7
pubmed: 10669205
J Biophotonics. 2017 Mar;10(3):385-393
pubmed: 26990139
Vision Res. 1999 Sep;39(18):3071-81
pubmed: 10664805
Nat Neurosci. 2009 Oct;12(10):1229-37
pubmed: 19749747
Orphanet J Rare Dis. 2019 Feb 18;14(1):46
pubmed: 30777126
J Neurosci. 2009 May 13;29(19):6068-77
pubmed: 19439584
Ann Neurol. 2015 Nov;78(5):775-86
pubmed: 26332183
Vision Res. 1999 Feb;39(3):569-74
pubmed: 10341985
Mol Autism. 2019 Nov 29;10:41
pubmed: 31798818
Proc Natl Acad Sci U S A. 2019 Oct 1;116(40):20097-20103
pubmed: 31527255